Test-Tube Baby

Description

“Test-tube baby” is a term used to refer to a baby produced through artificial insemination or in vitro fertilization, also called IVF. During artificial insemination, a physician injects carefully selected sperm into a women’s uterus to fertilize her eggs. During

“Test-tube baby” is a term used to refer to a baby produced through artificial insemination or in vitro fertilization, also called IVF. During artificial insemination, a physician injects carefully selected sperm into a women’s uterus to fertilize her eggs. During IVF, a trained professional harvests eggs from a female donor. Those eggs are fertilized with carefully selected sperm in a petri dish. Those fertilized eggs are allowed to divide and grow in the dish for four days, at which point the trained professional inserts those eggs into the uterus of a female so she can carry the pregnancy.

Date Created
2021-08-13

Rh Incompatibility in Pregnancy

175195-Thumbnail Image.jpg
Description

Rh factor is a protein found on the outside of Rh-positive red blood cells. Rh incompatibility during pregnancy occurs when an Rh-negative mother is pregnant with an Rh-positive fetus. During delivery, the fetus' Rh-positive blood is introduced into the mother’s

Rh factor is a protein found on the outside of Rh-positive red blood cells. Rh incompatibility during pregnancy occurs when an Rh-negative mother is pregnant with an Rh-positive fetus. During delivery, the fetus' Rh-positive blood is introduced into the mother’s body. The Rh-negative mother’s body begins to produce antibodies that attack and kill Rh-positive blood cells. Since the crossover of blood normally occurs during delivery, an Rh-negative woman’s first pregnancy is normally not affected. However, the woman’s antibodies may attack a second Rh-positive fetus as those antibodies can cross into the bloodstream and destroy fetal Rh-positive blood cells.

Date Created
2021-08-15

Thesis: Reviving the Dead, Ignoring the Living: Emotions, Ethics, and the Dream of De-Extinction

173119-Thumbnail Image.png
Description

The goal of this research project was to examine how different messaging techniques, and especially expressions of emotionality surrounding the loss and recovery of biodiversity, can differently influence public attitudes about conservation and the environment. This question was explored using

The goal of this research project was to examine how different messaging techniques, and especially expressions of emotionality surrounding the loss and recovery of biodiversity, can differently influence public attitudes about conservation and the environment. This question was explored using the case of de-extinction, an emerging and controversial conservation technology. De-extinction claims to “resurrect” extinct species, challenging widely held notions of extinction as permanent. Yet seeing extinction as reversible may shift how people feel about biodiversity loss and our moral responsibility to stop it.

Date Created
2021-11-30

“Mesenchymal and Induced Pluripotent Stem Cells: General Insights and Clinical Perspectives” (2015), by Helena D. Zomer, Antanásio S. Vidane, Natalia G. Gonçalves, and Carlos E. Ambrósio

173114-Thumbnail Image.png
Description

In 2015, biologist Helena D. Zomer and colleagues published the review article “Mesenchymal and Induced Pluripotent Stem Cells: General Insights and Clinical Perspectives” or “Mesenchymal and Induced Pluripotent Stem Cells” in Stem Cells and Cloning: Advances and Applications. The authors

In 2015, biologist Helena D. Zomer and colleagues published the review article “Mesenchymal and Induced Pluripotent Stem Cells: General Insights and Clinical Perspectives” or “Mesenchymal and Induced Pluripotent Stem Cells” in Stem Cells and Cloning: Advances and Applications. The authors reviewed the biology of three types of pluripotent stem cells, embryonic stem cells, or ESCs, mesenchymal stem cells, or MSCs, and induced pluripotent stem cells, or iPS cells. Pluripotent stem cells are a special cell type that can give rise to other types of cells and are essential for development. The authors describe the strengths and weaknesses of each type of stem cell for regenerative medicine applications. They state that both MSC and iPS types of stem cells have the potential to regenerate tissues among many other therapeutic possibilities. In their article, Zomer and colleagues review the potential for MSCs and iPS cells to reshape the field of regenerative and personal medicine.

Date Created
2021-08-04

A Series of YouTube Videos Detailing the “CRISPR Babies” Experiment (2018), by He Jiankui

173112-Thumbnail Image.png
Description

In 2018, He Jiankui uploaded a series of videos to a YouTube channel titled “The He Lab” that detailed one of the first instances of a successful human birth after genome editing had been performed on an embryo using CRISPR-cas9.

In 2018, He Jiankui uploaded a series of videos to a YouTube channel titled “The He Lab” that detailed one of the first instances of a successful human birth after genome editing had been performed on an embryo using CRISPR-cas9. CRISPR-cas9 is a genome editing tool derived from bacteria that can be used to cut out and replace specific sequences of DNA. He genetically modified embryos at his lab in Shenzhen, China, to make them immune to contracting HIV through indirect perinatal transmission from their father, who was infected with the virus. HIV is a virus that attacks the immune cells of its host and weakens their ability to fight off diseases. At the time of He’s experiment, various treatments already existed at that could prevent the fetuses from contracting HIV without the need for gene surgery. Nonetheless, He’s experiment led to one of the first successful births of fetuses resulting from genetically modified embryos. He kept his experiment secret until he uploaded the videos announcing the birth of the fetuses, born as two twin girls. The experiment discussed in the videos was successful, but many scientists criticized the experiment due to ethical concerns with the way He conducted it.

Date Created
2021-07-31

Biological Sex and Gender in the United States

173103-Thumbnail Image.png
Description

In the United States, most people are assigned both a biological sex and gender at birth based on their chromosomes and reproductive organs. However, there is an important distinction between biological sex and gender. Biological sex, such as male, female,

In the United States, most people are assigned both a biological sex and gender at birth based on their chromosomes and reproductive organs. However, there is an important distinction between biological sex and gender. Biological sex, such as male, female, or intersex, commonly refers to physical characteristics. Gender refers to the socially constructed roles, behaviors, and actions people take on, usually in relation to expectations of masculinity or femininity. As of 2022, there is disagreement over the relation between sex and gender. People’s biological sex and gender greatly influence the way they understand themselves, as well as how others treat them and how they interact with society. Moreover, some people’s gender differs from what they were assigned at birth, and they face discrimination, harassment, and violence. Evolving understandings of gender and sex in the US have created more ways for people to live and express their gender identities.

Date Created
2022-06-13

John Langdon Down (1828–1896)

173100-Thumbnail Image.png
Description

John Langdon Down studied medicine in England in the nineteenth century and was one of the first people to develop a complete description of the disorder that would later be known as Trisomy 21, or Down Syndrome. Down Syndrome is

John Langdon Down studied medicine in England in the nineteenth century and was one of the first people to develop a complete description of the disorder that would later be known as Trisomy 21, or Down Syndrome. Down Syndrome is a condition caused by the presence of an extra chromosome, which may cause a person to be born with certain impaired learning abilities and physical features such as a short neck, flattened face, and almond-shaped eyes. In 1866, Down published one of the first accounts to accurately describe people with Down Syndrome, or what he called “Mongolism,” and identify it as a distinct condition. Additionally, Down advocated for people with mental disabilities at a time when their families commonly abandoned them and medical professionals did not prioritize them. He improved the quality of care for people in the centers he worked in and increased their educational opportunities so they would be better prepared to live a normal life. Down brought increased attention to Down Syndrome, leading to the future discovery of the chromosomal anomaly that causes the disorder, and promoting a higher standard of care for people with mental disabilities.

Date Created
2021-08-12

George Otto Gey (1899-1970)

173087-Thumbnail Image.png
Description

George Otto Gey was a scientist in the US who studied cells and cultivated the first continuous human cell line in 1951. Gey derived the cells for that cell line, called the HeLa cell line, from a woman called Henrietta

George Otto Gey was a scientist in the US who studied cells and cultivated the first continuous human cell line in 1951. Gey derived the cells for that cell line, called the HeLa cell line, from a woman called Henrietta Lacks, a Black woman who had cervical cancer. Cell lines are a cluster of cells that continuously multiply on their own outside of the organism from which they originated. Gey developed new techniques for in vitro, or laboratory-based, maintenance of organs and hormonal tissue, created new methods for cell cultivation, and researched nutritional media, or cell food. Much of his research involved tissue culture, which is the process by which cells are grown under controlled conditions. He also founded what is now known as the Tissue Culture Association, or the TCA, which centered around furthering laboratory research around tissue culturing. By introducing new techniques and methods to cultivate human cells, Gey expanded the laboratory techniques around cell cultivation and helped contribute to a deeper understanding of the human body for future scientific research.

Date Created
2022-03-21

Jérôme Lejeune (1926−1994)

173085-Thumbnail Image.png
Description

Jérôme Lejeune was a French physician and researcher who studied genetics and developmental disorders. According to the Jérôme Lejeune Foundation, in 1958, Lejeune discovered that the existence of an extra twenty-first chromosome, a condition called Trisomy 21, causes Down Syndrome.

Jérôme Lejeune was a French physician and researcher who studied genetics and developmental disorders. According to the Jérôme Lejeune Foundation, in 1958, Lejeune discovered that the existence of an extra twenty-first chromosome, a condition called Trisomy 21, causes Down Syndrome. Down Syndrome is a condition present in an individual since birth and is characterized by physical and developmental anomalies such as small ears, a short neck, heart defects, and short height as children and adults. Throughout his career, Lejeune also discovered that other developmental disorders, such as cri du chat (cry of the cat) syndrome, were caused by chromosomal abnormalities. Lejeune also used his influence in the scientific community to promote pro-life beliefs, and often met with Pope John Paul II to discuss ethical dilemmas such as abortion of fetuses after detection of chromosomal abnormalities. Lejeune was one of the first researchers to link chromosomal abnormalities to developmental disorders with his discovery of Trisomy 21, leading future researchers to identify more links between the two.

Date Created
2021-08-19